Preliminary research indicate conolidine may well inhibit specific ion channels, minimizing neuronal excitability and restricting ache signals. This system is particularly relevant in neuropathic discomfort, in which irregular signaling will cause persistent distress. On top of that, conolidine seems to impact G protein-coupled receptor (GPCR) pathways integral to pain https://cassx271hon3.csublogs.com/profile